Ovid Therapeutics, Inc. (OVID)

1.60 +0.15 (+10.34%) USD  |  NASDAQ  |  Feb 06, 16:00
1.57 -0.03 (-1.88%) After-Hours: 20:00
More

Ovid Therapeutics SG&A Expense (TTM) : 22.56M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for OVID.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Ionis Pharmaceuticals, Inc. 351.68M
Cassava Sciences, Inc. 68.06M
AnaptysBio, Inc. 45.14M
Cogent Biosciences, Inc. 51.34M
Lyell Immunopharma, Inc. 49.04M